Dow Up 0.71% Nasdaq Up 1.20%

Theravance Inc. (THRX)

-NasdaqGS
15.62 Down 0.59(3.64%) 9:50AM EDT - Nasdaq Real Time Price
Prev Close:16.21
Open:15.62
Bid:15.58 x 500
Ask:15.93 x 200
1y Target Est:28.00
Beta:1.12
Next Earnings Date:N/A
Day's Range:15.58 - 16.46
52wk Range:15.56 - 32.89
Volume:51,080
Avg Vol (3m):798,464
Market Cap:1.80B
P/E (ttm):N/A
EPS (ttm):-2.09
Div & Yield:0.50 (3.00%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
THRXDown 3.64%1.80B
AZNUp 0.01%91.71B
CBSTUp 1.89%5.62B
PFEUp 0.85%190.83B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):822.04
Ex-Dividend Date:26-Aug-14

Analysts

Annual EPS Est (Dec-14) :-1.35
Quarterly EPS Est (Dec-14) :-0.08
Mean Recommendation*:2.7
PEG Ratio (5 yr expected):0.07

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Theravance, Inc., a royalty management company, is focused on developing respiratory products. It receives royalty revenues RELVAR/BREO ELLIPTA (fluticasone furoate/vilanterol, FF/VI), ANORO ELLIPTA (umeclidinium bromide/vilanterol, UMEC/VI), and ... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback